Valuation: Cosmos Health Inc.

Market Cap 2.79Cr 2.5Cr 2.3Cr 2.08Cr 3.9Cr 265.16Cr 3.97Cr 27Cr 11Cr 139.48Cr 10Cr 10Cr 439.87Cr P/E 2026 *
-1.85x
P/E 2027 * 3.96x
Enterprise Value 2.79Cr 2.5Cr 2.3Cr 2.08Cr 3.9Cr 265.16Cr 3.97Cr 27Cr 11Cr 139.48Cr 10Cr 10Cr 439.87Cr EV / Sales 2026 *
0.33x
EV / Sales 2027 * 0.22x
Free-Float
74.12%
Yield 2026 *
-
Yield 2027 * -
1 day+9.19%
1 week+14.87%
Current month-30.26%
1 month-30.26%
3 months+49.83%
6 months-18.22%
Current year-39.80%
1 week 0.22
Extreme 0.2182
0.3
1 month 0.22
Extreme 0.2182
0.42
Current year 0.16
Extreme 0.1616
0.59
1 year 0.16
Extreme 0.1616
0.95
3 years 0.16
Extreme 0.1616
1.65
5 years 0.16
Extreme 0.1616
113.75
10 years 0.16
Extreme 0.1616
312.5
Manager TitleAgeSince
Chief Executive Officer 60 26/02/2016
Director of Finance/CFO 43 11/11/2020
Chief Operating Officer 56 01/02/2023
Director TitleAgeSince
Director/Board Member 58 13/01/2014
Chairman 60 26/02/2016
Director/Board Member 59 18/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
30/07/26 Buy

Chief Executive Officer

3,49,825 0.5635%
29/07/26 Free

Chief Financial Officer

3,28,407 0.5290%
29/07/26 Buy

Chief Executive Officer

7,66,284 1.2344%
Change 5-day change 1-year change 3-year change Capi.($)
+9.19%+14.87%-66.70%-70.89% 2.79Cr
+2.94%+10.78%+67.05%+149.38% 1,22400Cr
-0.46%+3.78%+44.82%+86.21% 66TCr
+1.08%+2.95%+28.86%+107.25% 51TCr
+0.42%+3.20%+54.15%+67.18% 39TCr
+2.50%+2.92%+73.28%+45.61% 36TCr
+1.12%+4.52%+35.30%+58.08% 30TCr
+6.96%+8.86%+11.27%+36.62% 27TCr
+1.43%+6.14%+59.67%+77.15% 25TCr
+3.66%+9.57%+44.36%+119.85% 21TCr
Average +2.91%+3.30%+35.21%+67.64% 41.77TCr
Weighted average by Cap. +1.98%+3.04%+50.70%+97.89%

Financials

2026 *2027 *
Net sales 8.54Cr 7.65Cr 7.04Cr 6.38Cr 12Cr 810.96Cr 12Cr 84Cr 34Cr 426.59Cr 32Cr 31Cr 1.35TCr 13Cr 12Cr 11Cr 9.67Cr 18Cr 1.23TCr 18Cr 127.32Cr 51Cr 647.32Cr 49Cr 48Cr 2.04TCr
Net income 59.66L 53.43L 49.15L 44.53L 83.24L 57Cr 84.8L 5.86Cr 2.35Cr 30Cr 2.24Cr 2.19Cr 94Cr 88.12L 78.92L 72.59L 65.78L 1.23Cr 84Cr 1.25Cr 8.66Cr 3.48Cr 44Cr 3.31Cr 3.24Cr 138.8Cr
Net Debt - -
Projected Income Statement - Annual - Cosmos Health Inc.
Logo Cosmos Health Inc.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Employees
163
Date Price Change Volume
31/26/31 $0.2997 +8.00% 18,58,063
29/26/29 $0.2775 +11.45% 18,53,481
28/26/28 $0.2490 +5.51% 26,31,620
27/26/27 $0.2360 +1.55% 22,99,933
26/26/26 $0.2324 -10.96% 33,09,286
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Cosmos Health Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2775USD
Average target price
2.950USD
Spread / Average Target
+963.06%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cosmos Health Inc.
  1. Stock Market
  2. Stocks
  3. COSM Stock